Viking Therapeutics, Inc. (VKTX)

NASDAQ: VKTX · Real-Time Price · USD

30.89

+0.21 (0.68%)

At close: May 22, 2026, 4:00 PM EDT

30.85

-0.04 (-0.13%)

After-hours: May 22, 2026, 7:59 PM EDT

Viking Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	118.12	165.81	26.68	55.52	36.63	26.37
Short-Term Investments	484.85	539.93	875.94	306.56	118.85	175.73
Cash & Short-Term Investments	602.96	705.74	902.61	362.08	155.49	202.1
Cash Growth	-29.22%	-21.81%	149.29%	132.87%	-23.07%	-18.63%
Other Current Assets	5.25	9.86	4.6	5.15	11.56	8.43
Total Current Assets	608.21	715.6	907.22	367.23	167.04	210.53
Net Property, Plant & Equipment	-	0.09	1	1.13	1.42	0.03
Other Long-Term Assets	0.03	0.05	0.1	0.14	0.07	0.11
Total Assets	608.24	715.73	908.32	368.49	168.53	210.66
Accounts Payable	67.18	53.25	9.81	7.51	8.53	1.44
Accrued Expenses	39.14	23.28	17.11	11.3	13.11	7.31
Current Portion of Leases	-	0.14	0.49	0.32	0.3	0.03
Total Current Liabilities	106.33	76.67	27.41	19.14	21.95	8.78
Long-Term Leases	-	-	0.63	0.94	1.26	-
Total Long-Term Liabilities	-	-	0.63	0.94	1.26	-
Total Liabilities	106.33	76.67	28.04	20.07	23.21	8.78
Common Stock	0	0	0	0	0	0
Treasury Stock	-	-	-	-6.8	-6.8	-
Additional Paid-in Capital	1,509	1,486	1,369	733.55	445.27	425.61
Accumulated Other Comprehensive Income	-0.86	0.38	-0.79	-0.39	-1.1	-0.55
Retained Earnings	-1,006	-847.55	-487.91	-377.94	-292.05	-223.18
Shareholders' Equity	501.92	639.06	880.28	348.42	145.32	201.88
Total Liabilities & Equity	608.24	715.73	908.32	368.49	168.53	210.66
Total Debt	-	0.14	1.12	1.26	1.56	0.03
Net Cash (Debt)	602.96	705.6	901.49	360.82	153.92	202.07
Net Cash Growth	-14.55%	-21.73%	149.85%	134.42%	-23.83%	-18.53%
Net Cash Per Share	5.31	6.26	8.27	3.82	2.00	2.62
Book Value	501.92	639.06	880.28	348.42	145.32	201.88
Book Value Per Share	4.42	5.67	8.07	3.69	1.89	2.62
Tangible Book Value	501.92	639.06	880.28	348.42	145.32	201.88
Tangible Book Value Per Share	4.42	5.67	8.07	3.69	1.89	2.62

Updated Apr 30, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q